YOLFTbeta
Patrangsit Healthcare Group Public Company Limited

Patrangsit Healthcare Group Public Company Limited

PHG · BK · Healthcare / Medical Care Facilities

9.80THB+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close9.80
Open9.80
Day Range9.75 – 9.80
52-Week Range9.80 – 13.38
Volume4.94K
Market Cap3.00B
P/E (TTM)12.82
Forward P/E0.00
EPS0.78
Dividend Yield7.00%
Beta0.15
50-Day Avg10.24
200-Day Avg11.46

About

Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, pediatric dental, pediatric skin, pediatric gastrointestinal tract and liver, pediatric nervous system, orthopedic surgery, chest and heart surgery, general surgery, urology surgery, neurosurgery, obstetrics and gynecology, ear, nose, throat, internal medicine, gastrointestinal and liver medicine, neuro medicine, pulmonary and respiratory, cardiology, hematology, pediatric pulmonary and respiratory, skin clinic, and pediatrics allergy services. It also provides pediatrics heart and kidney, hemodialysis, health check-up, radiology and laboratory, men's health services, gastrointestinal tract endoscopy, chemotherapy, and women oncology services. Patrangsit Healthcare Group Public Company Limited was incorporated in 1984 and is based in Pathum Thani, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Kanawat Chantaralawan
  • Employees0
  • Headquarters733/345, 733/359 Moo 8, Pathum Thani, Thailand, 12130, Thailand
  • Websitehttps://www.patrangsit.com

Leadership

  • Mr. Kanawat ChantaralawanCEO & Director
  • Mr. Saran WangsuekulDeputy Chief Finance Officer
  • Dr. Tanarat LayangkurMember of Executive Board
  • Ms. Chandra LuangaramMember of Executive Board
  • Ms. Wararat PruekarapornMember of Executive Board
  • Mr. Apirak PreechsomboonDeputy Chief General Administration Officer
  • Dr. Teeranan MitrpanonDirector of Rangsit General Hospital
  • Ms. Supasjee BoonketDirector & Deputy Hospital Director

Financials

Income Statement

Currency: THB2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.97B2.04B2.14B2.27B2.51B
Growth (%)-+3.49%+4.81%+6.32%+10.29%
Cost of Revenue1.34B1.43B1.56B1.74B1.88B
Gross Profit630.14M607.98M573.31M534.62M627.06M
Gross Margin31.97%29.81%26.82%23.52%25.01%
Operating Expense217.13M228.15M238.93M218.12M239.03M
Operating Income413.01M379.83M334.37M316.49M388.03M
Operating Margin20.95%18.62%15.64%13.92%15.48%
EBITDA-449.77M417.10M411.25M493.48M
EBITDA Margin-22.05%19.51%18.09%19.68%
Net Income317.48M293.10M259.47M252.24M309.47M
Net Income Margin16.11%14.37%12.14%11.10%12.34%
Interest Expense12.30M11.95M9.78M1.16M528.03K
Interest Expense % of Total Revenue0.62%0.59%0.46%0.05%0.02%

Balance Sheet

Currency: THB2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.48B1.62B2.36B2.42B2.60B
Total Liabilities705.17M648.57M399.84M368.48M392.30M
Total Equity772.26M975.50M1.96B2.05B2.21B
Cash189.26M183.95M275.09M129.13M337.68M
Net Debt177.37M133.79M---

Cash Flow

Currency: THB2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-305.05M334.85M375.45M321.64M368.76M
Financing Cash Flow--113.76M-148.67M433.97M-202.61M-154.47M
Capital Expenditure057.66M87.53M140.39M111.37M72.14M
Free Cash Flow-247.39M247.33M235.05M210.27M296.61M
Dividends Paid-100.00M233.00M380.00M155.99M147.14M
FCF to OCF-81.10%73.86%62.61%65.38%80.44%
Dividend Paid to FCF-40.42%94.21%161.66%74.19%49.61%

Earnings

Report DateSep 30, 2023Dec 31, 2023May 14, 2024Aug 13, 2024Nov 12, 2024Feb 26, 2025May 14, 2025Aug 29, 2025Nov 18, 2025Mar 4, 2026May 20, 2026Aug 12, 2026
EPS Estimate------------
EPS Actual0.270.340.220.120.300.200.260.290.270.220.150.15
Surprise------------
Timing---Pre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap3.00B
Enterprise Value2.08B
Trailing P/E12.82
Forward P/E0.00
Price / Sales1.22
Price / Book1.46
EPS0.78
Book Value6.96
Revenue (TTM)2.46B
Gross Profit (TTM)555.84M
EBITDA355.43M
Profit Margin9.52%
Operating Margin7.21%
Return on Equity11.29%
Return on Assets6.55%
Shares Outstanding300.00M
Shares Float134.87M
Beta0.15
Dividend Yield7.00%
Dividend Rate0.70
Payout Ratio89.50%

Dividends

20261×
0.70May 5, 2026
20251×
0.50May 6, 2025
20241×
0.52Apr 18, 2024